INTECH Investment Management’s Stoke Therapeutics STOK Stock Holding History

INTECH Investment Management’s Portfolio STOK Stock Details STOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$400K	Sell	12,237 -2,257	-16%	-$72.4K	﹤0.01%	1450
2026 Q1	$472K	Sell	14,494 -4,158	-22%	-$136K	﹤0.01%	1356
2025 Q4	$592K	Buy	18,652 +5,505	+42%	+$165K	0.01%	1417
2025 Q3	$309K	Sell	13,147 -5,070	-28%	-$86.9K	﹤0.01%	1812
2025 Q2	$207K	Sell	18,217 -4,117	-18%	-$39.1K	﹤0.01%	2073
2025 Q1	$149K	Buy	22,334 +5,918	+36%	+$55.2K	﹤0.01%	2200
2024 Q4	$181K	Buy	16,416 +3,364	+26%	+$41.3K	﹤0.01%	2061
2024 Q3	$160K	Buy	+13,052	New	+$185K	﹤0.01%	1789

Other funds holding STOK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LCM

Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

INTECH Investment Management's STOK Position: Q2 2026 in Review

INTECH Investment Management reduced its Stoke Therapeutics (STOK) stake by 16% in Q2 2026, selling an estimated $72.4K and leaving 12,237 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #1450.

INTECH Investment Management first reported a position in STOK in Q3 2024 and has held it in 8 quarters since. The position peaked at $592K in Q4 2025. 197 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

INTECH Investment Management held 12,237 shares of Stoke Therapeutics worth $400K as of Q2 2026.
INTECH Investment Management sold 2,257 Stoke Therapeutics shares in Q2 2026, an estimated $72.4K.
Stoke Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1450 holding.
INTECH Investment Management first reported a position in Stoke Therapeutics in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Stoke Therapeutics position peaked at $592K in Q4 2025.
197 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.